Cal. Civ. Code § 460.060
Reimbursement for Mandatory Screening Services
Operative Text
The following blood lead screening services shall constitute the “Mandatory Blood Lead Screening”
in accordance with 105 CMR 460.050 and is required to be covered under policies of insurance as
provided by M.G.L. c. 175, § 47C, hospital service contracts as provided by M.G.L. c. 176A, § 8B,
medical service contracts as provided by M.G.L. c. 176B, § 4C, and health maintenance contracts as
provided by M.G.L. c. 176G, § 4, and shall be reimbursable:
(A) Assessment of the child for regular screening at age four, in accordance with 105 CMR
460.050(C), and assessment for high-risk screening, in accordance with 105 CMR 460.050(D).
(B) Completion of the laboratory form known as a bloodslip.
(C) Drawing of the blood specimen pursuant to 105 CMR 460.050(B).
(D) Packaging and handling of the blood specimen including postage costs for mailing the specimen
to the laboratory.
(E) Analysis of the blood specimen for lead level by atomic absorption spectrophotometry or any
other method approved by the Clinical Laboratory Improvement Amendments of 1988, Public Law
100-578, to § 353 of the Public Health Service Act, 42 U.S.C. 263a, and for erythrocyte
protoporphyrin by fluorometry, either through the measurement of zinc protoporphyrin or by extraction.Under 105 Mass. Code Regs. 460.060, Massachusetts law designates a specific set of blood lead screening services as 'Mandatory Blood Lead Screening,' which must be covered and reimbursed by health insurers, hospital service plans, medical service plans, and health maintenance organizations. The covered services include risk assessments, completion of required laboratory forms, blood specimen collection, packaging and mailing of specimens, and laboratory analysis using approved testing methods. This provision ensures that the cost of these screening steps cannot be excluded from qualifying insurance coverage in Massachusetts.
Plain English — not legal advice.
While 105 Mass. Code Regs. 460.060 is primarily directed at insurers and healthcare providers rather than property owners, landlords operating in Massachusetts should be aware that mandatory blood lead screening for children is a recognized part of the state's lead-poisoning prevention framework. Compliant property owners generally maintain lead-safe or lead-free certifications and cooperate with inspection and remediation requirements that work alongside screening mandates like those in § 460.060. Understanding that these screenings are insurance-reimbursable helps landlords appreciate the broader regulatory environment in which lead-related obligations exist.
General guidance for property managers — not legal advice for your specific situation. Consult an attorney for advice on your case.
Section 105 Mass. Code Regs. 460.060 establishes that a defined set of blood lead screening services for children must be reimbursed by health insurance policies, hospital service contracts, medical service contracts, and health maintenance contracts in Massachusetts. Tenants with children who have undergone blood lead screening may have grounds to challenge an insurer's refusal to cover these services by referencing this provision. Tenant-rights organizations or a state insurance consumer assistance program can provide general information about how to raise a coverage dispute if a claim under § 460.060 is denied.
General guidance for tenants — not legal advice for your specific situation. Consult a tenant-rights organization or attorney for advice on your case.
Generated September 30, 2026 — auto-generated, not yet human-reviewed. See /transparency for methodology.
Effective Timeline
References Out
No outbound references recorded yet for this provision.
References In
No inbound references recorded yet for this provision.